Achieve Life Sciences, Inc. (ACHV) DCF Valuation

Achieve Life Sciences, Inc. (ACHV) DCF Valuation
  • Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • Aucune Expertise N'Est Requise; Facile À Suivre

Achieve Life Sciences, Inc. (ACHV) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Discover the true potential of Achieve Life Sciences, Inc. (ACHV) with our professional-grade DCF Calculator! Adjust key assumptions, explore various scenarios, and assess the effects of changes on Achieve Life Sciences' valuation – all conveniently within one Excel template.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019
AY2
2020
AY3
2021
AY4
2022
AY5
2023
FY1
2024
FY2
2025
FY3
2026
FY4
2027
FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -16.1 -14.5 -32.9 -40.3 -26.7 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .3 .3 .3 .2 .2 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -16.4 -14.7 -33.2 -40.6 -27.0 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 16.7 35.9 43.0 24.8 15.5 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .2 .1 .1
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 -2.5 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .9 .3 .8 1.7 .6 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.1 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -16.1 -14.7 -32.9 -40.1 -27.0 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -15.1 -15.0 -32.3 -36.5 -30.3 -.5 .0 .0 .0 .0
WACC, % 12.84 12.87 12.86 12.85 12.89 12.86 12.86 12.86 12.86 12.86
PV UFCF
SUM PV UFCF -.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt 1
Equity Value -2
Diluted Shares Outstanding, MM 20
Equity Value Per Share -0.08

What You Will Receive

  • Comprehensive Financial Model: Achieve Life Sciences’ actual data facilitates accurate DCF valuation.
  • Complete Forecasting Flexibility: Modify revenue growth, profit margins, WACC, and other essential parameters.
  • Real-Time Calculations: Automatic updates provide immediate results as adjustments are made.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation.
  • Adaptable and Reusable: Designed for versatility, allowing for repeated application in detailed forecasting.

Key Features

  • 🔍 Real-Life ACHV Financials: Pre-filled historical and projected data for Achieve Life Sciences, Inc. (ACHV).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Achieve Life Sciences’ intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Achieve Life Sciences’ valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Download: Obtain the pre-built Excel file containing Achieve Life Sciences, Inc.'s (ACHV) financial data.
  • Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various forecasts and evaluate results instantly.
  • Make Decisions: Leverage the valuation findings to inform your investment approach.

Why Choose This Calculator for Achieve Life Sciences, Inc. (ACHV)?

  • User-Friendly Interface: Perfect for both novices and seasoned professionals.
  • Customizable Inputs: Adjust variables to tailor your analysis to specific scenarios.
  • Real-Time Feedback: Monitor immediate changes to Achieve Life Sciences’ valuation as you modify inputs.
  • Preloaded Data: Comes equipped with Achieve Life Sciences’ latest financial information for effortless analysis.
  • Relied Upon by Experts: A tool favored by investors and analysts for making strategic decisions.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Achieve Life Sciences, Inc. (ACHV) stock.
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models for Achieve Life Sciences, Inc. (ACHV).
  • Consultants: Deliver professional valuation insights for Achieve Life Sciences, Inc. (ACHV) to clients quickly and accurately.
  • Business Owners: Understand how biotech companies like Achieve Life Sciences, Inc. (ACHV) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios from Achieve Life Sciences, Inc. (ACHV).

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Achieve Life Sciences, Inc. (ACHV) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Achieve Life Sciences, Inc. (ACHV).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.